General Information of Drug (ID: DM6XNJR)

Drug Name
SC-46553 Drug Info
Synonyms Ginsenoside 20-Glc-Rf; PubChem13034; SC-46553; ZINC238808898; ginsenoside-Rd; 705G938; CHEMBL525935; S597; Ginsenoside Rd
Cross-matching ID
PubChem CID
24721561
INTEDE Drug ID
DR2742

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Malaria -1.66 4.62e-2 44/50 (88%) ACKR1;SDC2;ITGB2;...
Inflammatory bowel disease -1.68 3.99e-2 58/65 (89.23%) IL12RB2;HLA-DMB;IFNGR2;...
Galactose metabolism -1.73 2.72e-2 26/31 (83.87%) GLB1;HK1;G6PC2;...
Leishmaniasis -1.78 1.48e-2 67/77 (87.01%) HLA-DMB;FCGR2A;IFNGR2;...
Intestinal immune network for IgA production -1.80 1.45e-2 38/48 (79.17%) ICOSLG;HLA-DMB;CD80;...
Cell adhesion molecules -1.81 1.28e-2 118/148 (79.73%) PVR;CNTNAP2;HLA-DOA;...
Autoimmune thyroid disease -1.81 1.38e-2 46/53 (86.79%) FASLG;HLA-DPA1;HLA-F;...
Hematopoietic cell lineage -1.84 8.66e-3 90/99 (90.91%) CD1C;IL4R;ITGA2B;...
Viral myocarditis -1.84 8.59e-3 53/60 (88.33%) SGCG;HLA-DMB;RAC3;...
Cytokine-cytokine receptor interaction -1.86 5.67e-3 246/295 (83.39%) LTA;CCL25;CXCR6;...
Antigen processing and presentation -1.91 2.10e-3 60/78 (76.92%) PDIA3;HLA-A;KIR3DL1;...
Primary immunodeficiency -1.92 2.36e-3 33/38 (86.84%) TNFRSF13B;DCLRE1C;AICDA;...
Asthma -1.98 0.00e+0 25/31 (80.65%) HLA-DMB;IL3;FCER1G;...
Pentose phosphate pathway -1.98 0.00e+0 25/30 (83.33%) TKT;H6PD;PGD;...
Viral protein interaction with cytokine and cytokine re... -2.02 0.00e+0 84/100 (84%) LTA;CCL25;CXCR4;...
Systemic lupus erythematosus -2.03 0.00e+0 45/135 (33.33%) SNRPD3;RO60;HLA-DMB;...
Allograft rejection -2.08 0.00e+0 32/38 (84.21%) HLA-E;HLA-DMB;CD80;...
Graft-versus-host disease -2.26 0.00e+0 32/42 (76.19%) HLA-A;KIR3DL1;HLA-E;...
Type I diabetes mellitus -2.34 0.00e+0 38/43 (88.37%) HLA-A;HSPD1;PTPRN;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SK-ES-1 CVCL_0627 Homo sapiens 1.11uM - 10uM 24H
Brain
Glioma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GI-1 CVCL_1230 Homo sapiens 1.11uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MDA-MB-468 CVCL_0419 Homo sapiens 1.11uM - 10uM 24H
Breast ductal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
T-47D CVCL_0553 Homo sapiens 1.11uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SNU-407 CVCL_5004 Homo sapiens 1.11uM - 10uM 24H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 1.11uM - 10uM 24H
HEC-1-A CVCL_0293 Homo sapiens 1.11uM - 10uM 24H
HEC-251 CVCL_2928 Homo sapiens 1.11uM - 10uM 24H
HEC-265 CVCL_2929 Homo sapiens 1.11uM - 10uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CJM CVCL_U797 Homo sapiens 1.11uM - 10uM 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHH-5 CVCL_1320 Homo sapiens 1.11uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1573 CVCL_1483 Homo sapiens 1.11uM - 10uM 24H
NCI-H838 CVCL_1594 Homo sapiens 1.11uM - 10uM 24H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BEN CVCL_1081 Homo sapiens 1.11uM - 10uM 24H
HCC95 CVCL_1276 Homo sapiens 1.11uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H2110 CVCL_1529 Homo sapiens 1.11uM - 10uM 24H
Muscle
Rhabdomyosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-204 CVCL_0134 Homo sapiens 1.11uM - 10uM 24H
Ovary
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OVTOKO CVCL_3114 Homo sapiens 1.11uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
22Rv1 CVCL_1045 Homo sapiens 1.11uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
IGR-37 CVCL_1303 Homo sapiens 1.11uM - 10uM 24H
Mel-HO CVCL_1402 Homo sapiens 1.11uM - 10uM 24H
SH-4 CVCL_1692 Homo sapiens 1.11uM - 10uM 24H
Urinary bladder
Bladder carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BC-3C CVCL_1079 Homo sapiens 1.11uM - 10uM 24H
Bladder transitional cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CAL-29 CVCL_1109 Homo sapiens 1.11uM - 10uM 24H